Skip to main content
SpringerLink
Log in

Skip constructs in spinal muscular atrophy: outcomes of a novel approach for posterior spinal instrumentation and fusion

  • Case Series
  • Published:
Spine Deformity Aims and scope Submit manuscript

Abstract

Purpose

Many children with spinal muscular atrophy (SMA) develop progressive spinal deformity, worsening already compromised pulmonary function and global spinal balance. Early results demonstrate that intrathecal administration of nusinersen, a recent FDA-approved drug, improves motor function and ventilator-free survival, necessitating preservation of intrathecal access when considering PSIF. The purpose of this study is to assess medium-term outcomes of a specialized approach for posterior spinal instrumentation and fusion (PSIF) to preserve intrathecal access in patients with SMA.

Methods

A retrospective review of patients with SMA undergoing PSIF at a single tertiary academic medical center during a 3-year period was completed. To facilitate intrathecal drug administration, the traditional approach to PSIF was modified to “skip” one or more intervertebral levels at the thoracolumbar junction. Clinical notes and radiographs were reviewed for postoperative outcomes including major coronal curve correction and complications, including loss of correction, hardware failure and surgical revision.

Results

Eight patients were identified, with a mean age of 12.7 ± 1.6 years and follow-up of 4 years. These patients had a mean preoperative major coronal curve of 56.4°, with mean curve correction of 35.2°. At follow-up, no patients experienced rod breakage, loss of correction, or postoperative chronic pain. Only one patient required revision surgery due to bony overgrowth at the skipped level after three and a half years.

Conclusion

Implementing the skip construct approach for PSIF in patients with SMA allows for scoliosis correction without compromising intrathecal drug delivery. Follow-up at 4 years reveals no adverse clinical events, hardware failure or loss of correction.

Level of evidence

IV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Chng SY, Wong YQ, Hui JH et al (2003) Pulmonary function and scoliosis in children with spinal muscular atrophy types II and III. J Paediatr Child Health 39(9):673–676

    Article  CAS  Google Scholar 

  2. Gozal D (2000) Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol 29(2):141–150

    Article  CAS  Google Scholar 

  3. Samaha FJ, Buncher CR, Russman BS et al (1994) Pulmonary function in spinal muscular atrophy. J Child Neurol 9(3):326–329

    Article  CAS  Google Scholar 

  4. Merlini L, Granata C, Bonfiglioli S et al (1989) Scoliosis in spinal muscular atrophy: natural history and management. Dev Med Child Neurol 31(4):501–508

    Article  CAS  Google Scholar 

  5. Sucato DJ (2007) Spine deformity in spinal muscular atrophy. J Bone Joint Surg Am 89(suppl 1):148–154

    Article  Google Scholar 

  6. Hensinger RN, MacEwen GD (1976) Spinal deformity associated with heritable neurological conditions: spinal muscular atrophy, Friedreich’s ataxia, familial dysautonomia, and Charcot–Marie–Tooth disease. J Bone Joint Surg Am 58:13–24

    Article  CAS  Google Scholar 

  7. Dubowitz V (1974) Benign infantile spinal muscular atrophy. Dev Med Child Neurol 16:672–675

    Article  CAS  Google Scholar 

  8. Haché M, Swoboda KJ, Sethna N et al (2016) Intrathecal injections in children with spinal muscular atrophy: nusinersen clinical trial experience. J Child Neurol 31(7):899–906

    Article  Google Scholar 

  9. Hua Y, Sahashi K, Hung G et al (2010) Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. Genes Dev 24:1634–1644

    Article  CAS  Google Scholar 

  10. Hua Y, Vickers TA, Okunola HL et al (2008) Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects Ital splicing in transgenic mice. Am J Hum Genet 82:834–848

    Article  CAS  Google Scholar 

  11. U.S. National Library of Medicine. Genetics home reference: SMN1 gene. https://ghr.nlm.nih.gov/gene/SMN1. Accessed 27 June 2017

  12. Clinical Trials, A Service of the U.S. National Institutes of Health. A study to assess the efficacy and safety of nusinersen (ISIS 396443) in participants with later-onset spinal muscular atrophy (SMA) (CHERISH).https://clinicaltrials.gov/ct2/show/NCT02292537. Accessed 22 June 2017

  13. Main M, Kairon H, Mercuri E et al (2003) The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol 7(4):155–159

    Article  Google Scholar 

  14. Mercuri E. Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): end of study results from the phase 3 CHERISH study. American Academy of Neurology. American Academy of Neurology. 22 Apr 2017; Boston, MA. http://phx.corporate-ir.net/External.File?t = 1&item = VHlwZT0yfFBhcmVudElEPTUyNTE0NTV8Q2hpbGRJRD02Njc0MzY = Accessed 20 June 2017

  15. Weaver JJ, Natarajan N, Dhaw DWW et al (2018) Transforaminal intrathecal delivery of nusinersen using cone-beam computed tomography for children with spinal muscular atrophy and extensive surgical instrumentation: early results of technical success and safety. Pediatr Radiol 48(3):392–397. https://doi.org/10.1007/s00247-017-4031-6(Epub 2017 Nov 13)

    Article  PubMed  Google Scholar 

  16. Wurster CD, Winter B, Wollinsky K et al (2019) Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients. J Neurol 266(1):183–194. https://doi.org/10.1007/s00415-018-9124-0(Epub 2018 Nov 20)

    Article  PubMed  Google Scholar 

  17. Mousa MA, Aria DJ, Schaefer CM et al (2018) A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy. Pediatr Radiol 48(12):1797–1805. https://doi.org/10.1007/s00247-018-4206-9 (Epub 2018 Jul 18)

    Article  PubMed  Google Scholar 

  18. Miladi L, Gaume M, Khouri N et al (2018) Minimally invasive surgery for neuromuscular scoliosis. Spine 43(16):E968–E975

    Article  Google Scholar 

Download references

Acknowledgements

This work was conducted without the support of additional funding.

Funding

No funding was received for this work.

Author information

Authors and Affiliations

  1. Department of Pediatric Orthopaedic Surgery, Morgan Stanley Children’s Hospital of New York Presbyterian, Columbia University Medical Center, ATTN: Michael Vitale, 3959 Broadway, CHONY 8-N, New York, NY, 10032-3784, USA

    Matthew W. Konigsberg, Hiroko Matsumoto, Jacob R. Ball, Benjamin D. Roye & Michael G. Vitale

Authors
  1. Matthew W. Konigsberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroko Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jacob R. Ball
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Benjamin D. Roye
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael G. Vitale
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MWK: data interpretation, drafting manuscript, revising manuscript, final approval. HM: conception and design, data analysis, data interpretation, final approval. JRB: data interpretation, drafting manuscript, revising manuscript, final approval. BDR: resources, Conception and design, data interpretation, revision, final approval. MGV: resources, conception and design, supervision, final approval.

Corresponding author

Correspondence to Michael G. Vitale.

Ethics declarations

IRB approval/research ethics committee

This work is approved by the Institutional Review Board at Columbia University (Protocol AAAS0358).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Konigsberg, M.W., Matsumoto, H., Ball, J.R. et al. Skip constructs in spinal muscular atrophy: outcomes of a novel approach for posterior spinal instrumentation and fusion. Spine Deform 8, 1093–1097 (2020). https://doi.org/10.1007/s43390-020-00107-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43390-020-00107-3

Keywords

Search

Navigation